Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06246539 · ClinicalTrials.gov registry record · NA
Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness
A NA study, sponsored by University of Massachusetts, Worcester.
- Not yet
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06246539: Clinical Trial NA study, sponsored by University of Massachusetts, Worcester.
NCT06246539 is a NA study that has not yet begun recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06246539, a NA study, has not yet begun recruiting, sponsored by University of Massachusetts, Worcester.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Burnout shares symptoms with anxiety and depression. While there is no single intervention for burnout, there are validated interventions (which are amenable to virtual reality (VR)) for anxiety and depression. UMassMemorial data from the Professional Well-Being Academic Consortium show that MD burnout and distress has increased since 2020. The investigators believe providing clinicians with a unique tool (VR) will be a feasible and efficacious way to tackle distress. It is known that only 1% of our MDs have done mindfulness training but nearly 50% are interested in doing so. Therefore, a self-administrable, interactive mindfulness program delivered over VR has great potential to reach clinicians who want to practice a more active form of mindfulness at a time convenient to them. The results of the study will provide preliminary evidence to determine if a take-home VR mindfulness program decreases clinician stress.
Primary Outcome
PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.
Interventions
- BEHAVIORAL VR mindfulness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What is known before NCT06246539 opens enrollment
NCT06246539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which VR mindfulness is the first listed.
NCT06246539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06246539 about?
NCT06246539 is a clinical study titled "Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness". Burnout shares symptoms with anxiety and depression. While there is no single intervention for burnout, there are validated interventions (which are amenable to virtual reality (VR)) for anxiety and depression. UMassMemorial data from the Professional Well-Being Academic Consortium show that MD burn...
What is the current status of trial NCT06246539?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-06-01. Estimated completion is 2028-07-31.
What interventions are being tested in trial NCT06246539?
The interventions under investigation include: VR mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT06246539?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06246539's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI